Definitive Bimodality Concurrent Chemoradiotherapy in Patients with Inoperable N2-positive Stage IIIA Non-small Cell Lung Cancer

PURPOSE: This study was conducted to evaluate the treatment outcomes following definitive bimodality concurrent chemoradiotherapy (CCRT) in patients with inoperable N2-positive stage IIIA (N2-IIIA) non-small cell lung cancer (NSCLC). MATERIALS AND METHODS: From May 1997 to December 2012, 65 out of 6...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cancer Res Treat
Main Authors: Noh, Jae Myoung, Ahn, Yong Chan, Lee, Hyebin, Pyo, Hongryull, Kim, BoKyong, Oh, Dongryul, Park, Hyojung, Lee, Eonju, Park, Keunchil, Ahn, Jin Seok, Ahn, Myung-Ju, Sun, Jong-Mu
Formato: Artigo
Idioma:Inglês
Publicado: Korean Cancer Association 2015
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4614181/
https://ncbi.nlm.nih.gov/pubmed/25687864
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2014.144
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares